Within-group differences in the markers of platelet activation, endothelial cell activation, and stress response
| . | HAP group, DVT (n = 36) vs CVT (n = 14) . | SLP group, DVT (n = 31) vs CVT (n = 12) . |
|---|---|---|
| P-selectin, ng/mL | 16.11 (1.22-59.43)* | 16.14 (5.13-36.43)† |
| CD40L, ng/mL | 1.01 (−0.42 to 2.72) | 0.34 (−0.58 to 1.9) |
| PF4, ng/mL | 1.46 (−1.09 to 5.23) | 3.36 (−0.27 to 7.11) |
| ICAM1, ng/mL | 1.46 (−3 to 6.08) | 1.48 (−1.6 to 6.88) |
| VCAM, ng/mL | −0.03 (−3.69 to 2.75) | 1.16 (−0.71 to 3.6) |
| VEGF, ng/mL | 0.41 (−1.05 to 2.46) | 1.22 (−0.66 to 3.09) |
| FLT4/VEGFR3, ng/mL | 3.5 (−1.25 to 9.75) | 0.75 (−1.75 to 4.75) |
| TLR2, ng/mL | −0.07 (0.59 to 0.27) | 0.15 (−0.15 to 0.69) |
| E-selectin, ng/mL | 321.1 (−397.4 to 836.3) | −120.5 (−374.9 to 181.4) |
| HSP70, ng/mL | −2.42 (−11.25 to 4.67) | −0.83 (−2.08 to 0.5) |
| HIF-1α, fold expression | 0.34 (−0.16 to 0.94) | −0.06 (−0.32 to 0.18) |
| . | HAP group, DVT (n = 36) vs CVT (n = 14) . | SLP group, DVT (n = 31) vs CVT (n = 12) . |
|---|---|---|
| P-selectin, ng/mL | 16.11 (1.22-59.43)* | 16.14 (5.13-36.43)† |
| CD40L, ng/mL | 1.01 (−0.42 to 2.72) | 0.34 (−0.58 to 1.9) |
| PF4, ng/mL | 1.46 (−1.09 to 5.23) | 3.36 (−0.27 to 7.11) |
| ICAM1, ng/mL | 1.46 (−3 to 6.08) | 1.48 (−1.6 to 6.88) |
| VCAM, ng/mL | −0.03 (−3.69 to 2.75) | 1.16 (−0.71 to 3.6) |
| VEGF, ng/mL | 0.41 (−1.05 to 2.46) | 1.22 (−0.66 to 3.09) |
| FLT4/VEGFR3, ng/mL | 3.5 (−1.25 to 9.75) | 0.75 (−1.75 to 4.75) |
| TLR2, ng/mL | −0.07 (0.59 to 0.27) | 0.15 (−0.15 to 0.69) |
| E-selectin, ng/mL | 321.1 (−397.4 to 836.3) | −120.5 (−374.9 to 181.4) |
| HSP70, ng/mL | −2.42 (−11.25 to 4.67) | −0.83 (−2.08 to 0.5) |
| HIF-1α, fold expression | 0.34 (−0.16 to 0.94) | −0.06 (−0.32 to 0.18) |